Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | acrivastine | |
Synonyms |
BW 825C Semprex BW825C BW-825C 2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)- |
|
ID |
http://purl.bioontology.org/ontology/MESH/C043648 |
|
altLabel |
BW 825C Semprex BW825C BW-825C 2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)-
|
|
cui |
C0733885 C0592107 C0054340
|
|
Has mapping qualifier | ||
HM |
D014311/Q000031
|
|
Inverse of RB |
A20F9XAI7W
|
|
isa | ||
LT |
TRD
|
|
Mapped to | ||
MDA |
19850103
|
|
MeSH Frequency |
71
|
|
MMR |
20161221
|
|
notation |
C043648
|
|
PA |
D039563
|
|
prefLabel |
acrivastine
|
|
RR |
87848-99-5
|
|
SC |
1
|
|
Scope Statement |
a second generation antihistamine
|
|
SRC |
Dermatologica 1984;169(4):179
|
|
TERMUI |
T158316 T621868 T158314 T158317 T158315
|
|
TH |
UK NL NLM (1985) INN (19XX) FDA SRS (2015) USAN (1985)
|
|
tui |
T109 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping